Hims & Hers Health (HIMS) said Wednesday it has acquired at-home lab testing provider Sigmund, or Trybe Labs, to allow the company to offer at-home blood testing.
Financial terms were not disclosed.
The company said it funded the purchase with cash on hand and expects to introduce at-home testing over the next year.
Shares of Hims & Hers were up more than 4% in early trading Wednesday.
Price: 60.95, Change: +2.45, Percent Change: +4.19
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.